Dissolution Tests As A Drug Development Tool: Concept Gets FDA Panel Review

The assessment technique has mostly been seen as a confirmatory, not exploratory, process, but FDA will ask its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology to weigh in on research needed to correlate in vitro dissolution testing with in vivo drug performance.

More from United States

More from North America